Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
Crossref DOI link: https://doi.org/10.1007/s12325-019-01147-6
Published Online: 2019-11-14
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Carrasco, Joao
Pietsch, Georg-Alexander
Nicolas, Marie-Pierre
Koerber, Cecile
Bennison, Craig
Yoon, Jisu
Funding for this research was provided by:
Bayer Consumer Care AG
Text and Data Mining valid from 2019-11-14
Version of Record valid from 2019-11-14
Article History
Received: 2 October 2019
First Online: 14 November 2019